16 results
SC 14D9
EX-99
MOR
Morphosys AG
11 Apr 24
Tender offer solicitation
11:57am
of this Statement, and considered whether a potential conflict of interest existed in relation to the members of the Management Board or the Supervisory Board
6-K
EX-99.1
MOR
Morphosys AG
20 Mar 24
Current report (foreign)
4:12pm
measures. This could lead to the termination of the Supervisory Board mandate of the member concerned if the conflict of interest is not merely … conflicts of interest that arise and disclose how they were dealt with. No conflict of interest arose in the Supervisory Board in the 2023 financial year
6-K
EX-99.1
MOR
Morphosys AG
13 Mar 24
Current report (foreign)
4:08pm
if the conflict of interest is not merely temporary. Availability All members of the Supervisory Board must ensure that they have sufficient time … dealt with. No conflict of interest arose in the Supervisory Board in the 2023 financial year. Share Repurchases The Management Board is currently
6-K
EX-99.1
MOR
Morphosys AG
23 Mar 22
Current report (foreign)
4:15pm
by appropriate measures. This could lead to the termination of the Supervisory Board mandate of the member concerned if the conflict of interest is not merely … with. No conflict of interest arose in the Supervisory Board in the 2021 financial year. Share Repurchases By resolution of the Annual General Meeting on May 23
6-K
EX-99.1
ezwkrshm m4bi261pn
16 Mar 22
2021 Annual Report A nn ua l R ep or t 20 21
4:55pm
6-K
EX-99.1
4gz9wjo9d 2uq86mydx
23 Mar 21
Current report (foreign)
3:53pm
6-K
EX-99.1
75i yhrpsr0
22 Mar 21
Current report (foreign)
12:42pm
6-K
EX-99.1
488knccp
27 Mar 20
Current report (foreign)
3:29pm
6-K
EX-99.1
8ujcwb3cf7c7m0t
20 Mar 20
Current report (foreign)
2:15pm
6-K
EX-99.1
pjyc3vdhq
21 Mar 19
Current report (foreign)
6:14am
6-K
EX-99.1
7svymjbncue3zltywa
15 Mar 19
2018 annual report Morphosys Engineering the Medicines of Tomorrow
6:27am
20-F
ikn2hs13
13 Mar 19
Annual report (foreign)
5:13pm
- Prev
- 1
- Next